… The field of oncology is continuously evolving, with research focusing on developing more effective and personalized treatment modalities. One…
Browsing: Colorectal
… In the rapidly evolving field of oncology, colorectal cancer (CRC) represents a significant area of research and clinical development.…
In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual Disease (MRD). Dr. Mchayleh discusses…
By. Fairooz F. Kabbinavar, MD, FACP​ Date. 12/06/2023 Fairooz F. Kabbinavar, MD, FACP, a medical oncologist with a background in…
By. Filippo Pietrantonio, MD Date: 11/14/2023 Clinical data from the study demonstrated the inhibition of feedback reactivation pathways with an…
Marwan Fakih, MD – City of Hope – FDA Approval of LONSURF in combination with Bevacizumab The FDA approval of…
MOASC – Spotlight on Oncology Colorectal Cancer AbstractsDate: August 12, 2023Location: Huntington Beach, CAPresenter: Jason A. Zell, DO, MPHPosition: Professor,…
Colorectal cancer is a growing concern, and its incidence among younger individuals, known as young-onset colorectal cancer (yoCRC), has been…
BRAF V600E colon cancer is a subtype of colorectal cancer characterized by a specific genetic mutation known as BRAF V600E.…
… Metastatic colorectal cancer (mCRC) continues to be a significant health challenge worldwide. Despite advancements in treatment methods, the prognosis…
… The battle against cancer has led to a myriad of innovations in oncology, with each new breakthrough providing a…
Rona Yaeger, MD, an eminent oncologist from Memorial Sloan Kettering Cancer Center, is currently involved in a significant clinical trial…
The phase 3 FRESCO-2 study evaluated the efficacy and safety of fruquintinib, a novel targeted therapy, in patients with advanced…
J. Randolph Hecht, MD from UCLA Health is conducting a phase 3 clinical trial called STELLAR-303 to evaluate the efficacy…
Dr. Suneel Kamath from the Cleveland Clinic – Young onset colorectal cancer (yoCRC) has been increasing over the past few…
Ethnic Minorities: Empowering to Increase Colorectal Cancer Screening Through Community Outreach Kimlin Ashing PhD By Kimlin Tam Ashing, PhDProfessor, Department…
SOX9: Can this protein enable a molecular reversal that could lead to colorectal cancer? Nilay Sethi MD By Nilay Sethi,…
Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase 3 Trial Dr. David…
iFrame is not supported! Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase…
Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase 3 Trial Dr. David…
iFrame is not supported! KRAS G12C Sotorasib: [2022] An Updated Overview in CRC Update On The CodeBreaK 100 Trial/KRAS…
KRAS G12C Sotorasib: [2022] An Updated Overview in CRC Update On The CodeBreaK 100 Trial/KRAS G12C Sotorasib The CodeBreaK…
UCSF With FDA In Robotic Colorectal Surgery Trial: da Vinci SP [2022] Â The da Vinci SP Surgical Systems So…
Question and Answer Session May Cho, MD – ASCO 2022 Colon Cancer In-Depth Slides: MOASC Spotlight Link https://oncologytube.com/v/41298 May Cho,…
ASCO 2022 Colon Cancer In-Depth Slides: MOASC Spotlight  May Cho, MD from UCI Health ASCO (American Society of Clinical…
GI Genius vs Standard Colonoscopy: Is it Better? Â Rosario Ligresti, MD, FASGE Speaks About The GI Genius Intelligent Endoscopy…
ASCO (American Society of Clinical Oncology) 2022 Colon Cancer Overview: MOASC Spotlight  Today I presented three clinical trials at…
NRG-GI008 (CIRCULATE-US) Colon Cancer Overview [2022] To watch Dr. Arvind Dasari discuss the NRG-GI008 presentation with slides, Click Here! NRG-GI008…
NRG-GI008 (CIRCULATE-US) Colon Cancer Overview [2022] To watch Dr. Arvind Dasari discuss the NRG-GI008 presentation with slides, Click Here! NRG-GI008…
FRESCO-2 Trial Met Primary Endpoints in Patients With Metastatic Colorectal announced HUTCHMED from the Fruquintinib Global Phase III Trial The…
We completed a geospatial epidemiological study, examining colorectal cancer mortality among those diagnosed before the age of 50. And this…
In this interview, I will present the results of a translational analysis of the Italian drug study. AtezoTRIBE is a…
Heinz-Josef Lenz, MD, is a professor in the Departments of Medicine and Preventive Medicine in Keck School of Medicine’s oncology…
Heinz-Josef Lenz, MD, is a professor in the Departments of Medicine and Preventive Medicine in Keck School of Medicine’s oncology…
Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this audio, he speaks about the ASCO 2022…
Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this video, he speaks about the ASCO 2022…
Richard Kim, MD, Professor, clinical and research interests focus on gastrointestinal tumors, in particular, hepatobiliary and colon cancer at Moffitt…
Richard Kim, MD, Professor, clinical and research interests focus on gastrointestinal tumors, in particular, hepatobiliary and colon cancer at Moffitt…
Andrea Grace Bocobo, BS, Fourth-year medical student at Touro University California and Visiting Graduate Student at UCSF GI Oncology. In…
Andrea Grace Bocobo, BS, Fourth-year medical student at Touro University California and Visiting Graduate Student at UCSF GI Oncology. In…
Min Sun, MD, Ph.D., Oncologist, and Hematologist at UPMC Hillman Cancer Center, Clinical Assistant Professor at the University of Pittsburgh…
Min Sun, MD, Ph.D., Oncologist, and Hematologist at UPMC Hillman Cancer Center, Clinical Assistant Professor at the University of Pittsburgh…
Nageshwara Arvind Dasari, MD, Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine at MD Anderson Cancer…
Nageshwara Arvind Dasari, MD, Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine at MD Anderson Cancer…
Sue S. Yom, MD, Ph.D., Professor and Vice Chair, Strategic AdvisoryDepartment of Radiation Oncology; Professor, Otolaryngology-Head and Neck Surgery at…
Sue S. Yom, MD, Ph.D., Professor and Vice Chair, Strategic AdvisoryDepartment of Radiation Oncology; Professor, Otolaryngology-Head and Neck Surgery at…
Michael Cecchini, MD, Assistant Professor of Medicine (Medical Oncology); Co-Director, Colorectal Program in the Center for Gastrointestinal Cancers at Yale…
Michael Cecchini, MD, Assistant Professor of Medicine (Medical Oncology); Co-Director, Colorectal Program in the Center for Gastrointestinal Cancers at Yale…
Federico Aucejo, MD, is the Director of the Liver Cancer Program and Surgical Director of the Liver Tumor Clinic in…
Federico Aucejo, MD, is the Director of the Liver Cancer Program and Surgical Director of the Liver Tumor Clinic in…